Cognitive & Neuro Preliminary evidence

P21

P021

Also known as: P021, Ac-DGGL-amide derivative

In plain language

P21 is an experimental compound derived from a fragment of a neurotrophic factor, studied in animals for effects on memory and new neuron growth. There are no published human trials, so its effects and safety in people are unknown.

What it is explored for

P21 is an experimental compound with an appealing premise: supporting new neuron growth and memory pathways. It is important to be clear that all of the encouraging findings are preclinical, from animal and cell models, with no human trials yet. Here is where the research interest is currently focused.

  • New neuron growth research
  • Memory and learning research
  • BDNF signaling studies
  • Neuroprotection research
  • Alzheimer-model investigation

These are areas of active interest and reported use, not proven outcomes. This peptide carries a preliminary evidence rating, see the evidence summary below for how strong the science actually is.

How it works

P21 was designed from an active region of ciliary neurotrophic factor (CNTF). Its proposed mechanisms come from laboratory and animal models of neurodegeneration.

  • Neurogenesis. Reported to promote the growth of new neurons (neurogenesis) in animal models.
  • BDNF signaling. Associated with increased brain-derived neurotrophic factor (BDNF) activity in preclinical studies.
  • Tau and Alzheimer models. Reported in animal models to reduce abnormal tau changes linked to Alzheimer-type pathology.

All findings are preclinical (animal and cell studies). None have been confirmed in humans.

Evidence summary

The evidence for P21 is entirely preclinical. Animal studies, mostly in models of Alzheimer-type disease, report effects on neurogenesis and memory. There are no published human trials, so whether these effects translate to people is unknown.

Reported safety & side effects

There is no human safety data for P21. All available information comes from animal studies. Long-term effects, interactions, and risks in people are unknown.

Human safety dataNone; no human trials
Evidence baseAnimal and in-vitro studies only
Regulatory statusResearch use only; not approved

Frequently asked

Is there human evidence for P21?

No. All published research is in animals or cell models. There are no controlled human trials, so its effects and safety in people are not established.

What is P21 studied for?

It is studied mainly in animal models of Alzheimer-type disease for effects on new neuron growth and memory. These results have not been confirmed in humans.